Efficiency of second pegylated interferon and ribavirin combination treatment for the relapsed hepatitis C virus infection in low-income countries

Abstract

The current treatment for chronic hepatitis C virus (HCV) infection in Turkey is pegylated interferon (IFN) plus ribavirin combination. Patients who developed relapse following the first pegylated IFN plus ribavirin combination treatment are recommended to be treated by regimes in which protease inhibitors are combined with pegylated IFN plus ribavirin [1,2].